Membrane Environment Modulates Ligand-Binding Propensity of P2Y12 Receptor
The binding of natural ligands and synthetic drugs to the P2Y12 receptor is of great interest because of its crucial role in platelets activation and the therapy of arterial thrombosis. Up to now, all computational studies of P2Y12 concentrated on the available crystal structures, while the role of...
Main Authors: | Fatemeh Haghighi, Semen Yesylevskyy, Siamak Davani, Christophe Ramseyer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/4/524 |
Similar Items
-
Influence of Antiplatelet Agents on the Lipid Composition of Platelet Plasma Membrane: A Lipidomics Approach with Ticagrelor and Its Active Metabolite
by: Jennifer Lagoutte-Renosi, et al.
Published: (2021-01-01) -
Impact of ticagrelor on P2Y1 and P2Y12 localization and on cholesterol levels in platelet plasma membrane
by: Vahideh Rabani, et al.
Published: (2018-10-01) -
De-Escalation of Antiplatelet Treatment in Patients with Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Review of the Current Literature
by: Daniel MF Claassens, et al.
Published: (2020-09-01) -
A brief review on resistance to P2Y12 receptor antagonism in coronary artery disease
by: Ellen M. K. Warlo, et al.
Published: (2019-05-01) -
P2Y<sub>12</sub> Purinergic Receptor and Brain Tumors: Implications on Glioma Microenvironment
by: Fernanda Bueno Morrone, et al.
Published: (2021-10-01)